# A Study of DM005 in Patients With Advanced Solid Tumors

> **NCT06515990** · PHASE1 · RECRUITING · sponsor: **Doma Biopharmaceutical（Suzhou）Co., Ltd.** · enrollment: 136 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Squamous Cell Carcinoma of Head and Neck
- Solid Carcinoma

## Interventions

- **DRUG:** DM005

## Key facts

- **NCT ID:** NCT06515990
- **Lead sponsor:** Doma Biopharmaceutical（Suzhou）Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-31
- **Primary completion:** 2026-10
- **Final completion:** 2027-03
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06515990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06515990, "A Study of DM005 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06515990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*